Clinical implication of megestrol acetate in metastatic gastric cancer: a big data analysis from Health Insurance Review and Assessment (HIRA) database
ConclusionMA is commonly prescribed for metastatic gastric cancer, especially in elderly patients and those undergoing palliative chemotherapy, without significantly affecting survival or VTE risk.
Source: Supportive Care in Cancer - Category: Cancer & Oncology Source Type: research
More News: Anorexia | Cancer | Cancer & Oncology | Chemotherapy | Databases & Libraries | Eating Disorders & Weight Management | Gastric (Stomach) Cancer | Gastroenterology | Health Insurance | Insurance | Palliative | Statistics | Study | Thrombosis